MTW NHS Trust West Kent CCG

Drug Status Key

  • Preferred
  • Second Line
  • Third Line
  • Specialist Initiation
  • Hospital Only
  • Not Approved for Formulary

Antimuscarinics

Drug Safety Update

August 2022: Nebulised asthma rescue therapy in children: home use of nebulisers in paediatric asthma should be initiated and managed only by specialists

  July 2018: Pressurised metered dose inhalers (pMDI): risk of airway  obstruction from aspiration of loose objects

NICE Guidance

  NG115: Chronic obstructive pulmonary disease in over 16s - diagnosis and management, December 2018 (updated July 2019)

Local Guidance

See here for available local respiratory system guidance

Ipratropium and Spiriva Respimat are the only antimuscarinics licensed for asthma and COPD. The rest are licensed for COPD only.

Short-acting bronchodilator

Pack Price
200 dose £5.56
Pack Price
20 unit dose £6.65
60 unit dose

Long acting bronchodilator used twice daily. Each 375 microgram inhalation of aclidinium bromide delivers 322micrograms of aclidinium

Pack Price
60 dose £32.50

Long acting bronchodilator used once daily. Each capsule delivers 55 micrograms of glycopyrronium bromide equivalent to 44 micrograms of glycopyrronium

Pack Price
10 capsule
30 capsule £27.50
6 capsule

Long acting bronchodilator used once daily. Use Spiriva Respimat only when patients are unable to use Spiriva Handihaler.

Pack Price
30 capsule £33.50
60 capsule
Pack Price
30 capsule £34.87
Pack Price
60 dose £23.00

LAMA/LABA combination used once daily

Pack Price
10 capsule £10.83
30 capsule (3 x 10 capsules) £32.50